We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCN icon
1626
FTI Consulting
FCN
$4.22B
$129K 0.01%
811
-683
-46% -$114K
MHK icon
1627
Mohawk Industries
MHK
$9.26B
$129K 0.01%
1,261
-8,051
-86% -$790K
NOVA
1628
DELISTED
Sunnova Energy
NOVA
$129K 0.01%
7,188
-17,571
-71% -$354K
TEX icon
1629
Terex
TEX
$7.74B
$129K 0.01%
3,012
-3,519
-54% -$142K
TU icon
1630
Telus
TU
$15.2B
$129K 0.01%
6,707
+5,868
+699% +$121K
ANIK icon
1631
Anika Therapeutics
ANIK
$284M
$128K 0.01%
4,295
+2,694
+168% +$76.6K
ASB icon
1632
Associated Banc-Corp
ASB
$6.02B
$128K 0.01%
5,521
-21,832
-80% -$504K
BILI icon
1633
Bilibili
BILI
$7.53B
$128K 0.01%
5,416
+4,116
+317% +$65.5K
CALX icon
1634
Calix
CALX
$2.49B
$128K 0.01%
1,870
-9,710
-84% -$653K
IMCR icon
1635
Immunocore
IMCR
$1.74B
$128K 0.01%
2,241
-904
-29% -$50.9K
MSEX icon
1636
Middlesex Water
MSEX
$1.1B
$128K 0.01%
1,629
-1,854
-53% -$161K
SIBN icon
1637
SI-BONE Inc
SIBN
$843M
$128K 0.01%
9,435
+6,037
+178% +$88K
WK icon
1638
Workiva
WK
$3.76B
$128K 0.01%
1,528
-28
-2% -$2.17K
AMBP icon
1639
Ardagh Metal Packaging
AMBP
$3.02B
$127K 0.01%
26,318
+22,757
+639% +$104K
HBI
1640
DELISTED
Hanesbrands
HBI
$127K 0.01%
19,933
+2,466
+14% +$16.9K
LRGF icon
1641
iShares US Equity Factor ETF
LRGF
$3.7B
$127K 0.01%
3,252
-22,005
-87% -$861K
ONEM
1642
DELISTED
1Life Healthcare
ONEM
$127K 0.01%
7,621
-6,030
-44% -$102K
DVY icon
1643
iShares Select Dividend ETF
DVY
$23.7B
$126K 0.01%
1,044
+892
+587% +$106K
FERG icon
1644
Ferguson
FERG
$48.8B
$126K 0.01%
995
+930
+1,431% +$108K
KRUS icon
1645
Kura Sushi USA
KRUS
$600M
$126K 0.01%
2,647
+1,634
+161% +$109K
NTB icon
1646
Bank of N.T. Butterfield & Son
NTB
$2.49B
$126K 0.01%
4,206
-766
-15% -$25.3K
OGN icon
1647
Organon & Co
OGN
$3.58B
$126K 0.01%
4,492
-49,647
-92% -$1.27M
SNDX icon
1648
Syndax Pharmaceuticals
SNDX
$1.81B
$126K 0.01%
4,947
-2,288
-32% -$53.4K
UVIX icon
1649
2x Long VIX Futures ETF
UVIX
$214M
$126K 0.01%
2
-1
-33% -$91.3K
CTKB icon
1650
Cytek Biosciences
CTKB
$616M
$125K 0.01%
12,326
+4,082
+50% +$54.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.